American Century Companies Inc. Sells 5,920 Shares of Cigna Group $CI

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

American Century Companies Inc. lowered its holdings in shares of Cigna Group (NYSE:CI - Free Report) by 3.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 188,007 shares of the health services provider's stock after selling 5,920 shares during the period. American Century Companies Inc. owned approximately 0.07% of Cigna Group worth $61,854,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of CI. T. Rowe Price Investment Management Inc. acquired a new stake in Cigna Group in the fourth quarter worth approximately $724,517,000. Nuveen LLC bought a new stake in Cigna Group in the first quarter worth about $727,905,000. GAMMA Investing LLC raised its position in Cigna Group by 58,799.0% in the first quarter. GAMMA Investing LLC now owns 1,774,626 shares of the health services provider's stock worth $583,852,000 after acquiring an additional 1,771,613 shares in the last quarter. GQG Partners LLC lifted its holdings in Cigna Group by 21.5% in the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider's stock valued at $1,607,716,000 after acquiring an additional 865,092 shares during the last quarter. Finally, Two Sigma Advisers LP boosted its position in shares of Cigna Group by 278.0% during the 4th quarter. Two Sigma Advisers LP now owns 816,200 shares of the health services provider's stock valued at $225,385,000 after purchasing an additional 600,300 shares in the last quarter. Institutional investors own 86.99% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on Cigna Group and gave the stock a "buy" rating in a research note on Tuesday, August 5th. Guggenheim reissued a "buy" rating and issued a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Truist Financial boosted their price objective on Cigna Group from $385.00 to $405.00 and gave the stock a "buy" rating in a report on Monday, May 12th. Cowen reiterated a "buy" rating on shares of Cigna Group in a report on Monday, May 5th. Finally, Royal Bank Of Canada restated an "outperform" rating and set a $371.00 price target on shares of Cigna Group in a report on Thursday, June 26th. Two analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Cigna Group presently has a consensus rating of "Buy" and a consensus price target of $374.82.

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.70% of the company's stock.

Cigna Group Stock Up 1.1%

Shares of NYSE CI traded up $3.1890 during mid-day trading on Friday, reaching $304.1390. 1,127,473 shares of the company traded hands, compared to its average volume of 1,847,744. Cigna Group has a fifty-two week low of $256.89 and a fifty-two week high of $370.83. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The company's fifty day moving average is $301.16 and its two-hundred day moving average is $311.31. The stock has a market cap of $81.18 billion, a PE ratio of 16.60, a price-to-earnings-growth ratio of 0.89 and a beta of 0.47.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same quarter last year, the company posted $6.72 earnings per share. Cigna Group's quarterly revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th will be given a $1.51 dividend. The ex-dividend date is Thursday, September 4th. This represents a $6.04 annualized dividend and a yield of 2.0%. Cigna Group's payout ratio is presently 32.97%.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.